Inactive Instrument

Calendar Regulus Therapeutics Inc Nasdaq

Equities

US75915K1016

Chart calendar Regulus Therapeutics Inc

054bc45a9524a37b.L1IERxFUe1ZWThqwOA2Tpv6x3vGeLnxtqnLWJArLDqM.FjxQc2gLHBAmDSPEXmvD9seBurXoHisOmkCmT02fZsxgIGYodjgVLzg5aQ~92608f38e0bbad1ea409a568da217ef2

Upcoming events on Regulus Therapeutics Inc

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Regulus Therapeutics Inc

2024-03-21 04:05 pm Q4 2023 Earnings Release
2024-03-12 08:30 am Business Update Call
2024-01-04 Investor Meeting After hours
2023-11-29 10:25 am Evercore ISI HealthCONx Conference
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-09-20 08:30 am RGLS8429 Phase 1b Study Results Call
2023-09-11 11:00 am H.C. Wainwright Global Investment Conference
2023-09-06 11:00 am R&D Day
2023-09-05 Wells Fargo Healthcare Conference
2023-08-09 11:30 am Canaccord Genuity Growth Conference
2023-08-08 04:05 pm Q2 2023 Earnings Release
2023-07-25 03:00 pm H.C. Wainwright Kidney Conference
2023-06-01 12:00 pm Annual General Meeting
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-03-23 04:05 pm Q4 2022 Earnings Release
2023-03-08 Chronic Kidney Disease Drug Development Summit
2023-02-16 01:00 pm SVB Securities Global Biopharma Conference
2022-11-10 05:00 pm Q3 2022 Earnings Call
2022-11-10 04:05 pm Q3 2022 Earnings Release
2022-11-03 10:00 am American Society of Nephrology Kidney Week Conference - Abstract Number: 3768400

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
6,83
6,86
-0.38%
10,0
5,02
99.28%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-30,9
-30,7
-0.59%

-38,7

EBIT
Million USD
Released
Forecast
Spread
-16,8
-17,2
2.18%
-14,2
-19,2
26.36%
-27,8
-27,4
-1.42%
-28,2
-28,9
2.15%
-31,1
-30,9
-0.82%

-34,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-18,6
-18,9
1.85%
-15,7
-20,9
24.88%
-27,8
-26,9
-3.43%
-28,3
-29,1
2.67%
-30,0
-29,9
-0.47%

-34,4

Net income
Million USD
Released
Forecast
Spread
-18,6
-18,9
1.85%
-15,7
-20,9
24.86%
-27,8
-26,9
-3.43%
-28,3
-29,1
2.67%
-30,0
-30,0
-0.13%

-33,7

EPS
USD
Released
Forecast
Spread
-10,8
-11,0
1.82%
-4,50
-6,60
31.82%
-3,20
-3,27
2.04%
-1,86
-1,83
-1.82%
-1,58
-1,59
0.32%

-0,51

Announcement Date12/03/2009/03/2110/03/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-6,96
-6,57
-5.9%
-6,57
-7,21
8.84%
-7,18
-7,05
-1.77%
-7,56
-7,35
-2.9%
-6,93
-7,66
9.5%
-7,37
-7,08
-4.16%
-7,32
-7,51
2.55%
-8,13
-7,51
-8.19%
-8,30
-8,05
-3.11%

-8,70


-8,70


-9,55


-9,55




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-7,13
-6,14
-16.24%
-6,72
-7,20
6.75%
-7,26
-7,14
-1.67%
-7,55
-7,39
-2.13%
-6,80
-7,70
11.75%
-7,14
-6,99
-2.1%
-7,01
-7,34
4.41%
-7,82
-7,31
-6.99%
-8,06
-7,91
-1.94%

-8,56


-8,46


-9,33


-9,39




Net income
Million USD
Released
Forecast
Spread
-7,13
-6,14
-16.24%
-6,72
-7,20
6.73%
-7,26
-7,14
-1.67%
-7,55
-7,39
-2.13%
-6,80
-7,70
11.75%
-7,14
-6,99
-2.1%
-7,01
-7,34
4.39%
-7,82
-7,31
-6.99%
-8,06
-8,01
-0.7%

-8,07


-8,11


-8,92


-9,22




EPS
USD
Released
Forecast
Spread
-0,70
-0,67
-5%
-0,50
-0,53
6.25%
-0,50
-0,49
-3.09%
-0,50
-0,49
-2.04%
-0,40
-0,51
21.57%
-0,42
-0,44
3.82%
-0,37
-0,41
9.76%
-0,40
-0,40
-0.84%
-0,40
-0,40
-1.27%

-0,22


-0,11


-0,12


-0,12


-0,14

Announcement Date10/03/2212/05/2211/08/2210/11/2223/03/2311/05/2308/08/2309/11/2321/03/24-----
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Stock
  5. Calendar Regulus Therapeutics Inc